Dunhill Financial’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$610 Sell
9
-3
-25% -$200 ﹤0.01% 1103
2026
Q1
$760 Hold
12
﹤0.01% 1025
2025
Q4
$771 Buy
12
+4
+50% +$259 ﹤0.01% 869
2025
Q3
$553 Sell
8
-4
-33% -$317 ﹤0.01% 836
2025
Q2
$1.12K Sell
12
-64
-84% -$5.02K ﹤0.01% 754
2025
Q1
$5.16K Buy
76
+12
+19% +$979 ﹤0.01% 557
2024
Q4
$5.02K Sell
64
-16
-20% -$1.19K ﹤0.01% 536
2024
Q3
$5.34K Buy
80
+42
+111% +$3.45K ﹤0.01% 536
2024
Q2
$4.25K Buy
38
+8
+27% +$1.01K ﹤0.01% 419
2024
Q1
$4.13K Buy
30
+5
+20% +$628 ﹤0.01% 357
2023
Q4
$3.11K Buy
+25
New +$2.55K ﹤0.01% 367

Other funds holding DXCM

Dunhill Financial's DXCM Position: Q2 2026 in Review

Dunhill Financial reduced its DexCom (DXCM) stake by 25% in Q2 2026, selling an estimated $200 and leaving 9 shares worth $610. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

Dunhill Financial first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.34K in Q3 2024. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Dunhill Financial held 9 shares of DexCom worth $610 as of Q2 2026.
  • Dunhill Financial sold 3 DexCom shares in Q2 2026, an estimated $200.
  • DexCom made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1103 holding.
  • Dunhill Financial first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's DexCom position peaked at $5.34K in Q3 2024.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.